Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TERT promoter mutations in actinic keratosis before and after treatment.
Srinivas N, Neittaanmäki N, Heidenreich B, Rachakonda S, Karppinen TT, Grönroos M, Tani TT, Salmivuori M, Snellman E, Hemminki K, Kumar R. Srinivas N, et al. Among authors: kumar r. Int J Cancer. 2020 May 15;146(10):2932-2934. doi: 10.1002/ijc.32878. Epub 2020 Jan 30. Int J Cancer. 2020. PMID: 31970758 Free article. No abstract available.
TERT promoter mutations in cancer development.
Heidenreich B, Rachakonda PS, Hemminki K, Kumar R. Heidenreich B, et al. Among authors: kumar r. Curr Opin Genet Dev. 2014 Feb;24:30-7. doi: 10.1016/j.gde.2013.11.005. Epub 2013 Dec 20. Curr Opin Genet Dev. 2014. PMID: 24657534 Review.
TERT promoter mutations in clear cell renal cell carcinoma.
Hosen I, Rachakonda PS, Heidenreich B, Sitaram RT, Ljungberg B, Roos G, Hemminki K, Kumar R. Hosen I, et al. Among authors: kumar r. Int J Cancer. 2015 May 15;136(10):2448-52. doi: 10.1002/ijc.29279. Epub 2014 Oct 30. Int J Cancer. 2015. PMID: 25331263 Free article.
TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Andrés-Lencina JJ, Rachakonda S, García-Casado Z, Srinivas N, Skorokhod A, Requena C, Soriano V, Kumar R, Nagore E. Andrés-Lencina JJ, et al. Among authors: kumar r. Int J Cancer. 2019 Mar 1;144(5):1027-1036. doi: 10.1002/ijc.31780. Epub 2018 Oct 4. Int J Cancer. 2019. PMID: 30070694 Free article.
TERT promoter mutations in melanoma survival.
Nagore E, Heidenreich B, Rachakonda S, Garcia-Casado Z, Requena C, Soriano V, Frank C, Traves V, Quecedo E, Sanjuan-Gimenez J, Hemminki K, Landi MT, Kumar R. Nagore E, et al. Among authors: kumar r. Int J Cancer. 2016 Jul 1;139(1):75-84. doi: 10.1002/ijc.30042. Epub 2016 Mar 2. Int J Cancer. 2016. PMID: 26875008 Free PMC article.
TERT promoter mutations in telomere biology.
Heidenreich B, Kumar R. Heidenreich B, et al. Among authors: kumar r. Mutat Res Rev Mutat Res. 2017 Jan-Mar;771:15-31. doi: 10.1016/j.mrrev.2016.11.002. Epub 2016 Nov 23. Mutat Res Rev Mutat Res. 2017. PMID: 28342451 Review.
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K, Kumar R. Rachakonda PS, et al. Among authors: kumar r. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17426-31. doi: 10.1073/pnas.1310522110. Epub 2013 Oct 7. Proc Natl Acad Sci U S A. 2013. PMID: 24101484 Free PMC article.
18,355 results
You have reached the last available page of results. Please see the User Guide for more information.